Scientific Opinion on Ergot alkaloids in food and feed

EFSA Journal

Volumn 10, Issue 7, 2012, Pages

[No Author Info available]

Author keywords

analysis; chemistry; Ergot alkaloids (EAs); exposure; health based guidance value; origin; risk assessment

Indexed keywords

EID: 85051284214     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2012.2798     Document Type: Article

References (314)

1. Ács N, Bánhidy F, Puhó E and Czeizel AE, 2006. A possible dose-dependent teratogenic effect of ergotamine. Reproductive Toxicology, 22, 551–552.
2. Adams K, Allen JA, Brooker PC, Jones E, Proudlock RJ, Mailland F, Coppi G, 1993. Evaluation of the mutagenicity of a-dihydroergocryptine in vitro and in vivo. Arzneimittelforschung 43, 1253–1257.
3. Aellig WH, 1984. Investigation of the venoconstrictor effect of 8' hydroxydihydroergotamine, the main metabolite of dihydroergotamine, in man. European Journal of Clinical Pharmacology, 26, 239–242.
4. Aellig WH and Nüesch E, 1977. Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration in man. International Journal of Clinical Pharmacology and Biopharmacy, 15, 106–112.
5. AFRC (Agricultural and Food Research Council), 1993. Energy and Protein Requirements of Ruminants. An advisory manual prepared by the AFRC Technical Committee on Responses to Nutrients. CABI, Wallingford, UK, 176 pp.
6. AFSSA (Agence Française de Sécurité Sanitaire des Aliments), 2009. Évaluation des risques liés à la présence de mycotoxines dans le chaînes alimentaires humaines et animale. Rapport Final, May 2009.
7. AHFS (American Hospital Formulary Service), 1995. Drug Information. Ed McEvoy GK. American Society of Health-System; Pharmacists. 7272 Wisconsin Avenue, Bethesda, MD 20814.
8. American Academy of Pediatrics Committee on Drugs, 2001. Transfer of drugs and other chemicals into human milk. Pediatrics, 108, 776–789.
9. Appelt M and Ellner FM, 2009. Investigations into the occurrence of alkaloids in ergot and single sclerotia from the 2007 and 2008 harvests. Mycotoxin Research, 25, 95–101.
10. Ayers AW, Hill NS, Rottinghaus GE, Stuedemann JA, Thompson FN, Purinton PT, Seman DH, Dawe DL, Parks AH and Ensley D, 2009. Ruminal Metabolism and Transport of Tall Fescue Ergot Alkaloids. CropScience, 49, 2309–2316.
11. Bailey CA, Fazzino JJJ, Ziehr MS, Sattar M, Haq AU, Odvody G and Porter JK, 1999. Evaluation of sorghum ergot toxicity in broilers. Poultry Science, 78, 1391–1397.
12. Bandyopadhyay R, Frederickson DE, McLaren NW, Odvody GN and Ryley MJ, 1998. Ergot: A new disease threat to sorghum in the Americas and Australia. Plant Disease, 82, 356–367.
13. Bánhidy F, Ács N, Puhó E and Czeizel AE, 2007. Ergotamine treatment during pregnancy and a higher rate of low birthweight and preterm birth. British Journal of Clinical Pharmacology, 64, 510–516.
14. Banks GT, Mantle PG and Szczyrbak CA, 1974. Large-scale production of clavine alkaloids by Claviceps fusiformis. Journal of General Microbiology, 82, 345–361.
15. Battilani P, Costa LG, Dossena A, Gullino ML, Marchelli R, Galaverna G, Pietri A, Dall'Asta C, Giorni P, Spadaro D and Gualla A 2009. Scientific information on mycotoxins and natural plant toxicants. Scientific/Technical Report submitted to EFSA, CFP/EFSA/CONTAM/2008/01.
16. Baumann U, Hunziker HR and Zimmerli B, 1985. Ergot alkaloids in Swiss cereal products. Mitteilungen aus dem Gebiete der Lebensmitteluntersuchung und Hygiene, 76, 609–630.
17. Ben-Jonathan; N and Hnasko R, 2001. Dopamine as a prolactin (PRL) inhibitor. Endocrine Review, 22, 724–763.
18. Berntssen MH, Olsvik PA, Torstensen BE, Julshamn K, Midtun T, Goksoyr A, Johansen J, Sigholt T, Joerum N, Jakobsen JV, Lundebye AK and Lock EJ, 2010. Reducing persistent organic pollutants while maintaining long chain omega-3 fatty acid in farmed Atlantic salmon using decontaminated fish oils for an entire production cycle. Chemosphere, 81, 242–252.
19. BfR (Federal Institute for Risk Assessment), 2004. Mutterkornalkaloide im Roggenmehl. Stellungnahme des BfR vom 22.01 2004. Available from www.bfr.bund.de/cm/208/mutterkornalkaloide_in_roggenmehl.pdf.
20. BfR (Federal Institute for Risk Assessment), 2010. Presentation by Ch. Gottschalk, 5th CRL/NRL Workshop on Mycotoxins, Geel, 10–11 March, 2010.
21. Bicalho B, Giolo JM, Lilla S and De Nucci G, 2008. Identification and human pharmacokinetics of dihydroergotoxine metabolites in man: preliminary results. Biopharmaceutics & Drug Disposition, 29, 17–28.
22. Bicalho B, Guzzo GC, Lilla S, Dos Santos HO, Mendes GD, Caliendo G, Perissutti E, Aiello A, Luciano P, Santagada V, Pereira AS and De Nucci G, 2005. Pharmacokinetics of dihydroergocristine and its major metabolite 8'-hydroxy-dihydroergocristine in human plasma. Current Drug Metabolism, 6, 519–529.
23. Blaney BJ, Molloy JB and Brock IJ, 2009. Alkaloids in Australian rye ergot (Claviceps purpurea) sclerotia: implications for food and stockfeed regulations. Animal Production Science, 49, 975–982.
24. Blaney BJ, Ryley MJ and Boucher BD, 2010. Early harvest and ensilage of forage sorghum infected with ergot (Claviceps africana) reduces the risk of livestock poisoning. Australian Veterinary Journal, 88, 311–312.
25. Blaschek W, Ebel S, Hackenthal E, Holzgrabe U, Keller K, Reichling J and Schulz V, 2006. Hager ROM 2006. Hagers Handbuch der Drogen und Arzneistoffe. Springer Medizin Verlag, Heidelberg.
26. Bogun N, Mathies R and Bäsecke J, 2011. Angiospastic occlusion of the superficial femoral artery by chronic ergotamine intake. Deutsche Medizinische Wochenschrift, 136, 23–26.
27. Bové FJ, 1970. The story of ergot. Ed Karger S. Basel & New York, 297 pp.
28. Bracher F, Heisig P, Langguth P, Mutschler E, Rücker G, Scriba G, Stahl-Biskup; E and Troschütz R, 2010. Kommentar zum Europäischen Arzneibuch (Commentary to the Pharmacopoeia Europaea), Wissenschaftliche Verlagsgesellschaft, Stuttgart, Germany.
29. Brar SS, Giam CS and Taber WA, 1968. Patterns of in vitro ergot alkaloid production by Claviceps paspali and their association with different growth rates. Mycologia, 60, 806–826.
30. Brendemuehl JP, Williams MA, Boosinger TR and Ruffin DC, 1995. Plasma progestagen, tri-iodothyronine, and cortisol concentrations in postdate gestation foals exposed in utero to the tall fescue endophyte Acremonium coenophialum. In: Equine Reproduction VI. Biology of Reproduction, Monograph Series, 1, 53–59.
31. Browning LS, 1968. Lysergic acid diethylamine: mutagenic effects in Drosophila. Science, 161, 1022–1023.
32. Bruneton J, 1995. Pharmacognosy, phytochemistry, medicinal plants. Technique and Documentation –Lavoisier, Paris/Intercept LTD., Andover. p. 803.
33. Brunton LL, Lazo JS and Parker KL, 2006. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th edition. Ed McGraw-Hill;. New York, 1984 pp.
34. Buchheister GA and Ottersbach G, 1919. Handbuch der Drogisten-Praxis;. Ein Lehr-und Nachschlagebuch für Drogisten, Farbwarenhändler usw. 13. Edition. Ed Springer Verlag von Julius. Berlin, 118 pp.
35. Bürk G, Hobel W and Richt A, 2006. Ergot alkaloids in cereal products: results from the Bavarian Health and Food Safety Authority. Molecular Nutrition and Food Research, 50, 437–442.
36. Carpent G and Desclin L, 1969. Effects of ergocornine on the mechanism of gestation and on fetal morphology in the rat. Endocrinology, 84, 315–324.
37. CAST (Council for Agricultural Science and Technology), 2003. Mycotoxins: Risks in Plant, Animal, and Human Systems. Task force report, ISSN 0194–4088; no. 139. Council for Agricultural Science and Technology, Ames, Iowa, USA.
38. Cawdell-Smith; AJ, Scrivener CJ and Bryden WL, 2010. Staggers in horses grazing paspalum infected with Claviceps paspali. Australian Veterinary Journal, 88, 393–395.
39. Chen X, Zhong D, Xu H, Schug B and Blume H, 2002. Sensitive and specific liquid chromatographic-tandem mass spectrometric assay for dihydroergotamine and its major metabolite in human plasma. Journal of Chromatography. B, 768, 267–275.
40. Chestnut AB, Fribourg HA, Gwinn KD, Anderson PD and Cochran MA, 1991. Effect of ammoniation on toxicity of Acremonium-Coenophialum; infested tall fescue. Animal Feed Science and Technology, 35, 227–236.
41. Christensen MJ, Bennett RJ and Schmid J, 2002. Growth of Epichloë/Neotyphodium and p-endophytes in leaves of Lolium and Festuca grasses. Mycological Research, 106, 93–106.
42. Clarke EGC, Humphreys DJ and Harvey DG, 1981. Veterinary Toxicology. London: Bailliere Tindall, 438 pp.
43. Clay K and Schardl C, 2002. Evolutionary origins and ecological consequences of endophyte symbiosis with grasses. American Naturalist, 160, S99–S127.
44. Cohen MM, Marinello MJ and Back N, 1967. Chromosomal damage in human leukocytes induced by lysergic acid diethylamide. Science, 155, 1417–1419.
45. Cooke RM and Mitchell DT, 1966. Sclerotium size and germination in Claviceps purpurea. Transactions of the British Mycological Society, 49, 95–100.
46. Crews C, Anderson WAC, Rees G and Krska R, 2009. Ergot alkaloids in some rye-based UK cereal products. Food Additives and Contaminants. Part B, 2, 79–85.
47. Dabkevicius Z and Semaskiene R, 2001. Occurrence and harmfulness of ergot (Claviceps purpurea (Fr.) Tul.) in cereal crops of Lithuania. Biologija, 8–10.
48. Dargaville PA and Campbell NT, 1998. Overdose of ergometrine in the newborn infant: acute symptomatology and long-term outcome. Journal of Paediatrics and Child Health, 34, 83–89.
49. De Costa C, 2002. St Anthony's fire and living ligatures: a short history of ergometrine. Lancet, 359, 1768–1770.
50. de Groot AN, van Dongen PW, van Roosmalen J and Eskes TK, 1993. Ergotamine-induced fetal stress: review of side effects of ergot alkaloids during pregnancy. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 51, 73–77.
51. de Groot AN, Vree TB, Hekster YA, van den Biggelaar-Martea; M, van Dongen PW and van Roosmalen J, 1994. Pharmacokinetics and bioavailability of oral ergometrine in male volunteers. Biopharmaceutics and Drug Disposition, 15, 65–73.
52. De Lorme MJM, Lodge-Ivey; SL and Craig AM, 2007. Physiological and digestive effects of Neotyphodium coenophialum-infected tall fescue fed to lambs. Journal of Animal Science, 85, 1199–1206.
53. Demeke T, Kidane Y and Wuhib E, 1979. Ergotism-a report on an epidemic, 1977–78. Ethiopian Medical Journal, 17, 107–113.
54. Deviere J, Reuse C and Askenasi R, 1987. Ischemic pancreatitis and hepatitis secondary to ergotamine poisoning. Journal of Clinical Gastroenterology, 9, 350–352.
55. Diana Di Mavungu JD, Larionova DA, Malysheva SV, Van Peteghem C and De Saeger S 2011. Survey on ergot alkaloids in cereals intended for human consumption and animal feeding. Scientific report submitted to EFSA. Available from www.efsa.europa.eu/en/supporting/pub/214e.htm.
56. Dighe R and Vaidya VG, 1988. Induction of sister chromatid exchanges by ergot compounds in Chinese hamster ovary cells in vitro. Teratogenesis, Carcinogenesis, and Mutagenesis, 8, 169–174.
57. Dishotsky NI, Loughman WD, Mogar RE and Lipscomb WR, 1971. LSD and genetic damage. Science, 172, 431–440.
58. Donatini B, Le Blaye I and Krupp P, 1993. Inadvertent administration of uterotonics to neonates. Lancet, 341, 839–840.
59. Driehuis F, Spanjer MC, Scholten JM and te Giffel MC, 2008. Occurrence of mycotoxins in feedstuffs of dairy cows and estimation of total dietary intakes. Journal of Dairy Science, 91, 4261–4271.
60. Dubini F, Bignami P, Zanotti A, Coppi G, 1990. Mutagenicity studies on dihydroergocristine. Drugs Experimentalm and Clinical Research 16, 255–261.
61. Dusemund B, Altmann H-J and Lampen A, 2006. II. Toxikologische Bewertung Mutterkornalkaloid-kontaminierter; Roggenmehle. Journal of Consumer Protection and Food Safety, 1, 150–152.
62. Eadie MJ, 2003. Convulsive ergotism: epidemics of the serotonin syndrome? Lancet Neurology, 2, 429–434.
63. EFSA (European Food Safety Authority), 2005. Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the European Commission related to ergot as undesirable substance in animal feed. The EFSA Journal, 225, 1–27.
64. EFSA (European Food Safety Authority), 2006. Opinion of the Scientific Committee related to Uncertainties in Dietary Exposure Assessment. The EFSA Journal, 438, 1–57.
65. EFSA (European Food Safety Authority), 2009. Guidance of the Scientific Committee on Use of the benchmark dose approach in risk assessment. The EFSA Journal, 1150, 1–72.
66. EFSA (European Food Safety Authority), 2010a. Guidance of EFSA: Standard sample description for food and feed. EFSA Journal, 8(1):1457, 54 pp.
67. EFSA (European Food Safety Authority), 2010b. Scientific report of EFSA: Management of left-censored data in dietary exposure assessment of chemical substances. EFSA Journal, 8(3):1557, 96 pp.
68. EFSA (European Food Safety Authority), 2011a. Scientific Report of EFSA. Evaluation of the FoodEx, the food classification system applied to the development of the EFSA Comprehensive European Food Consumption Database. EFSA Journal, 9(3):1970, 27 pp.
69. EFSA (European Food Safety Authority), 2011b. Guidance of EFSA: Use of the EFSA Comprehensive European Food Consumption Database in Exposure Assessment. EFSA Journal, 9(3):2097, 34 pp.
70. EFSA (European Food Safety Authority), 2011c. Results on acrylamide levels in food from monitoring years 2007–2009. EFSA Journal, 9(4):2133, 48 pp.
71. EFSA (European Food Safety Authority), 2011d. Scientific Opinion on the riks for animal and public health related tot he presence of T-2 and HT2 toxin in food and feed. EFSA Journal, 9(12): 2481, 187 pp.
72. EFSA (European Food Safety Authority), 2012. Guidance on selected default values to be used by the EFSA Scientific Committee, Scientific Panels and Units in the absence of actual measured data. EFSA Journal, 10(3): 2759, 32 pp.
73. Eich E and Pertz H, 1994. Ergot alkaloids as lead structures for differential receptor systems. Pharmazie, 49, 867–877.
74. EMAN (European Mycotoxin Awareness Network), 2005. Mycotoxin Fact Sheets. In: European Mycotoxin Awareness Network. Available from www.mycotoxins.org/.
75. EMEA (European Agency for the Evaluation of Medicinal Products), 1999. Committee for veterinary medicinal products-Ergometrine maleate Summary Report. Veterinary Medicines Evaluation Unit. EMEA/MRL/237/97-FINAL, June 1999.
76. European Pharmacopoeia, 2008. 6th Edition. Council of Europe, Strasbourg.
77. Evans PJ, Lloyd JW and Peet KM, 1980. Autonomic dysaesthesia due to ergot toxicity. British Medical Journal, 281, 1621.
78. ® Service GmbH, Frankfurt/Main, Germany.
79. Fajardo JE, Dexter JE, Roscoe MM and Nowicki TW, 1995. Retention of Ergot Alkaloids in Wheat During Processing. Cereal Chemistry, 72, 291–298.
80. FEFAC (European Feed Manufacturers' Association), 2009. From Farm to Table 2008: Statistical brochure, FEFAC, June 2009. Available from www.fefac.org/statistics.aspx?EntryID=1103
81. Feng N, Minder EI, Grampp T and Vonderschmitt DJ, 1992. Identification and quantification of ergotamine in human plasma by gas chromatography-mass spectrometry. Journal of Chromatography, 575, 289–294.
82. Fisher PE, Silk DB, Menzies-Gow; N and Dingle M, 1985. Ergotamine abuse and extra-hepatic portal hypertension. Postgraduate Medical Journal, 61, 461–463.
83. Fitzgerald P and Dinan TG, 2008. Prolactin and dopamine: what is the connection? A review article. Journal of Psychopharmacology, 22, 12–19.
84. Fitzhugh OG, Nelson AA, Calvery HO, 1944. The chronic toxicity of ergot. Journal of Pharmacology and Experimental Therapeutics 82, 364–376.
85. Flieger M, Wurst M and Shelby R, 1997. Ergot alkaloids-sources, structures and analytical methods. Folia Microbiol (Praha), 42, 3–29.
86. Floss HG, Cassady JM and Robbers JE, 1973. Influence of ergot alkaloids on pituitary prolactin and prolactin-dependent processes. Journal of Pharmaceutical Sciences, 62, 699–715.
87. Flückiger E, 1976. The pharmacology of bromocriptine. In: Pharmacological and clinical aspects of bromocriptine (Parlodel). Eds Bayliss RIS, Turner P and Maclay WP. MCS Consultants, Tunbridge Wells, 12–26.
88. Foote AP, Harmon DL, Strickland JR, Bush LP and Klotz JL, 2011. Effect of ergot alkaloids on contractility of bovine right ruminal artery and vein. Journal of Animal Science, 89, 2944–2949.
89. Forth W, Henschler D and Rummel W, 2009. Allgemeine und spezielle Pharmakologie und Toxikologie. 10. ed. Urban & Fischer Verlag, München, Germany.
90. Franzmann C, Schroder J, Munzing K, Wolf K, Lindhauer MG and Humpf HU, 2011. Distribution of ergot alkaloids and ricinoleic acid in different milling fractions. Mycotoxin Research, 27, 13–21.
91. Franzmann C, Steinmeier A, Dittmer N and Humpf HU, 2010b. Mutterkorn in Roggen-Vorkommen, Nachweis und Stabilität der Mutterkornalkaloide. Cereal Technology, 4, 213–219.
92. Franzmann C, Wachter J, Dittmer N and Humpf HU, 2010a. Ricinoleic acid as a marker for ergot impurities in rye and rye products. Journal of Agricultural and Food Chemistry, 58, 4223–4229.
93. Friedman M, Dao L and Gumbmann MR, 1989. Ergot alkaloid and chlorogenic acid content in different varieties of Morning-glory (Ipomoea spp.) seeds. Journal of Agricultural Food Chemistry, 37, 708–712.
94. Fröhlich G, Kaplan V and Amann-Vesti; B, 2010. Holy fire in an HIV-positive man: a case of 21st-century ergotism. CMAJ - Canadian Medical Association Journal, 182, 378–380.
95. Frohne D and Pfaender HJ, 2004. Giftpflanzen; 5. Auflage, Wissenschaftliche Verlagsgesellschaft mbH Stuttgart.
96. Galer BS, Lipton RB, Solomon S, Newman LC and Spierings EL, 1991. Myocardial ischemia related to ergot alkaloids: a case report and literature review. Headache, 31, 446–450.
97. Gant DB, Cole RJ, Valdes JJ, Eldefrawi ME and Eldefrawi AT, 1987. Action of tremorgenic mycotoxins on GABAA receptor. Life Sciences, 41, 2207–2214.
98. Gibson DJ and Newman JA, 2002. Festuca arundinacea Schreber (F. elatior L. ssp. arundinacea (Schreber) Hackel). Journal of Ecology 89, 304–324.
99. Glatt H, Eich E, Pertz H, Becker C and Oesch F, 1987. Mutagenicity experiments on agroclavines, new natural antineoplastic compounds. Cancer Research, 47, 1811–1814.
100. Glatt H, Pertz H, Kasper R and Eich E, 1992. Clavine alkaloids and derivatives as mutagens detected in the Ames test. Anticancer Drugs, 3, 609–614.
101. Graf WD and Shepard TH, 1997. Uterine contraction in the development of Möbius syndrome. Journal of Child Neurology, 12, 225–227.
102. Graham JMJ, Marin-Padilla; M and Hoefnagel D, 1983. Jejunal atresia associated with Cafergot ingestion during pregnancy. Clinical Pediatrics, 22, 226–228.
103. Grauwiler J and Schön H, 1973. Teratological experiments with ergotamine in mice, rats, and rabbits. Teratology, 7, 227–235.
104. Griffith RW, Grauwiler J, Hodel C, Leist KH and Matter B, 1978. Ergot-toxicology considerations. In: Heffter-Heubner;'s Handbook of experimental pharmacology. 805–851.
105. Groger D, Tyler VE and Dusenberry JE, 1961. Investigations of the alkaloid of paspalum ergot. Lloydia, 24, 97–102.
106. Haarmann T, Rolke Y, Giesbert S and Tudzynski P, 2009. Ergot: from witchcraft to biotechnology. Molecular Plant Pathology, 10, 563–577.
107. Hafner M, Sulyok M, Schuhmacher R, Crews C and Krska R, 2008. Stability and epimerisation behaviour of ergot alkaloids in various solvents. World Mycotoxin Journal, 1, 67–78.
108. Handeland K and Vikøren T, 2005. Presumptive gangrenous ergotism in free-living moose and a roe deer. Journal of Wildlife Diseases, 41, 636–642.
109. Hannaway DB, Daly C, Halbleib MD, James D, West CP, Volenec JJ, Chapman D, Li X, Cao W, Shen J, Shi X and Johnson S, 2009. Development of suitability maps with examples for the United States and China. In: Tall Fescue for the Twenty-first Century. Agronomy Monograph No. 53. Madison, WI: American Society of Agronomy CropScience Society of America Soil Science Society of America, 33–47.
110. Hill NS, Thompson FN, Stuedemann JA, Rottinghaus GW, Ju HJ, Dawe DL and Hiatt EE, 2001. Ergot alkaloid transport across ruminant gastric tissues. Journal of Animal Science, 79, 542–549.
111. Hopkins AA, Young CA, Panaccione DG, Simpson WR, Mittal S and Bouton JH, 2010. Agronomic Performance and Lamb Health among Several Tall Fescue Novel Endophyte Combinations in the South-Central; USA. CropScience, 50, 1552–1561.
112. Hughes HE and Goldstein DA, 1988. Birth defects following maternal exposure to ergotamine, beta blockers, and caffeine. Journal of Medical Genetics, 25, 396–399.
113. Huybrechts I, Sioen I, Boon PE, Ruprich J, Lafay L, Turrini A, Amiano P, Hirvonen T, Neve MD, Arcella D, Moschandreas J, Westerlund A, Ribas-Barba; L, Hilbig A, Papoutsou S, Christensen T, Oltarzewski M, Virtanen S, Rehurkova I, Azpiri M, Sette S, Kersting M, Walkiewicz A, Serra-Majem; L, Volatier JL, Trolle E and de Neve M, 2011. Dietary exposure assessments for children in Europe (the EXPOCHI project): rationale, methods and design. Archives of Public Health, 69, 1–7.
114. Ibraheem JJ, Paalzow L and Tfelt-Hansen; P, 1982. Kinetics of ergotamine after intravenous and intramuscular administration to migraine sufferers. European Journal of Clinical Pharmacology, 23, 235–240.
115. Ibraheem JJ, Paalzow L and Tfelt-Hansen; P, 1983. Low bioavailability of ergotamine tartrate after oral and rectal administration in migraine sufferers. British Journal of Clinical Pharmacology, 16, 695–699.
116. IPC (International Psoriasis Council), 2012. The evolution of the clinical trials process-a brief history lesson, In “Conducting a clinical trial-what you need to know. International Psoriasis Council. Available from www.psoriasiscouncil.org/chapters/show/2.
117. Irwin S and Egozcue J, 1967. Chromosomal abnormalities in leukocytes from LSD-25 users. Science, 157, 313–314.
118. Janssen GB, Beems RB, Elvers LH and Speijers GJ, 2000b. Subacute toxicity of alpha-ergocryptine in Sprague-Dawley; rats. 2: metabolic and hormonal changes. Food and Chemical Toxicology, 38, 689–695.
119. Janssen GB, Beems RB, Speijers GJ and van Egmond HP, 2000a. Subacute toxicity of alpha-ergocryptine in Sprague-Dawley; rats. 1: general toxicological effects. Food and Chemical Toxicology, 38, 679–688.
120. Jegorov A, 1999. Analytical Chemistry of Ergot Alkaloids. In: Ergot - The Genus Claviceps. Eds Kren C and VCvak L. Harwood Academic Press, Amsterdam, The Netherlands, 267–303.
121. Jegorov A, Šimek P, Heydovaá A, Cvak L and Minár J, 1997. Free and bonded homoisoleucine in sclerotia of the parasitic fungus Claviceps purpurea. Amino Acids, 12, 9–19.
122. Jensen AMD, Mikkelsen L and Roulund N, 2007. Variation in genetic markers and ergovaline production in endophyte (Neotyphodium)-infected fescue species collected in Italy, Spain, and Denmark. CropScience, 47, 139–147.
123. Jeong SY, Lim ES, Shin BS, Seo MW, Kim YH, Kwak HS, Chung GH and Jeong SK, 2006. Ergotism with ischemia in all four extremities: a case report. Journal of Clinical Neurology, 2, 279–282.
124. Kalberer F, 1970. Absorption, distribution and excretion of [3H] ergotamine in the rat. Biopharmaceutical aspects. In: Ergot Alkaloids and Related compounds. Eds Berde B and Shild HO. Springer Verlag, New York,
125. Kato T and Jarvik LF, 1969. LSD-25 and genetic damage. Diseases of the Nervous System, 30, 42–46.
126. Kim JH, Kim CW, Ahn GC, Park EK, Kim CM and Park KK, 2007. Ergovaline levels in tall fescue and its effect on performance of lactating cows. Animal Feed Science and Technology, 136, 330–337.
127. King B, 1979. Outbreak of ergotism in Wollo, Ethiopia. Lancet, 1, 1411.
128. Klug C, Baltes W, Kronert W and Weber R, 1988. A method for the determination of ergot alkaloids in food. Zeitschrift fur Lebensmittel-Untersuchung; und -Forschung, 186, 108–113.
129. Kobel H, Schreier E and Rutschmann J, 1964. 6-Methyl-Delta;8,9-ergolen-8-carbonsäure, ein neues Ergolinderivat aus Kulturen eines Stammes von Claviceps paspali Stevens et Hall. Helvetica Chimica Acta, 47, 1052–1064.
130. Koi H, 1966. Clinical studies on the action of ergocornine in women. The Keio Journal of Medicine, 15, 197–212.
131. Kokkonen M and Jestoi M, 2010. Determination of ergot alkaloids from grains with UPLC-MS;/MS. Journal of Separation Science, 33, 2322–2327.
132. Komarova EL and Tolkachev ON, 2001a. Medicinal plants: the chemistry of peptide ergot alkaloids. Part 1. Classification and chemistry of ergot peptides. Pharmaceutical Chemistry Journal, 35, 504–513.
133. Komarova EL and Tolkachev ON, 2001b. The Chemistry of Peptide Ergot Alkaloids. Part 2. Analytical Methods for Determining Ergot Alkaloids. Pharmaceutical Chemistry Journal, 91, 542–549.
134. Kommission E, 1986. Secale cornutum (Mutterkorn), Bundesanzeiger, 18.09.1986, no. 173, p. 13285.
135. Kopinski JS, Blaney BJ, Downing JA, McVeigh JF and Murray SA, 2007. Feeding sorghum ergot (Claviceps africana) to sows before farrowing inhibits milk production. Australian Veterinary Journal, 85, 169–176.
136. Kopinski JS, Blaney BJ, Murray SA and Downing JA, 2008. Effect of feeding sorghum ergot (Claviceps africana) to sows during mid-lactation on plasma prolactin and litter performance. Journal of Animal Physiology and Animal Nutrition, 92, 554–561.
137. Kraicer PF and Strauss JF, 1970. Ovulation block produced by an inhibitor of luteotrophin, ergocornine. Acta Endocrinologica, 65, 698–706.
138. Krishnamachari KA and Bhat RV, 1976. Poisoning by ergoty bajra (pearl millet) in man. The Indian Journal of Medical Research, 64, 1624–1628.
139. Krska R and Crews C, 2008. Significance, chemistry and determination of ergot alkaloids: a review. Food Additives and Contaminants. Part A, 25, 722–731.
140. Krska R, Stubbings G, Macarthur R and Crews C, 2008. Simultaneous determination of six major ergot alkaloids and their epimers in cereals and foodstuffs by LC-MS;-MS. Analytical and Bioanalytical Chemistry, 391, 563–576.
141. Kucht S, Gross J, Hussein Y, Grothe T, Keller U, Basar S, Konig WA, Steiner U and Leistner E, 2004. Elimination of ergoline alkaloids following treatment of Ipomoea asarifolia (Convolvulaceae) with fungicides. Planta, 219, 619–625.
142. Lauber U, Schnaufer R, Gredziak M and Kiesswetter Y, 2005. Analysis of rye grains and rye meals for ergot alkaloids. Mycotoxin Research, 21, 258–262.
143. Lazarides MK, Karageorgiou C, Tsiara S, Grillia M and Dayantas JN, 1992. Severe facial ischaemia caused by ergotism. The Journal of Cardiovascular Surgery, 33, 383–385.
144. Lebas F and Renouf B, 2009. Nutrition: utilisation des matières premières et techniques d'alimentation. Cuniculture Magazine, 36, 12–64.
145. Lehner AF, Craig M, Fannin N, Bush L and Tobin T, 2004. Fragmentation patterns of selected ergot alkaloids by electrospray ionization tandem quadrupole mass spectrometry. Journal of Mass Spectrometry, 39, 1275–1286.
146. Lehner AF, Craig M, Fannin N, Bush L and Tobin T, 2005. Electrospray[+] tandem quadrupole mass spectrometry in the elucidation of ergot alkaloids chromatographed by HPLC: screening of grass or forage samples for novel toxic compounds. Journal of Mass Spectrometry, 40, 1484–1502.
147. LFGB, 2012. Amtliche Sammlung von Untersuchungsverfahren nach §64 FFGB (2012) Untersuchung von Lebensmitteln, Methode L 15.01/02 Bestimmung von Ergotalkaloiden in Roggen und Weizen. HPLC-Verfahren; mit Reinigung an einer basischen Aluminiumoxid-Festphase;. www.methodensammlung-bvl.de, Beuth Verlag GmbH, Berlin, Germany.
148. Li JH and Lin LF, 1998. Genetic toxicology of abused drugs: a brief review. Mutagenesis, 13, 557–565.
149. Lindner HR, Lunenfeld B and Shelesnyak MC, 1967. Plasma levels of progesterone and cortisol, and urinary pregnanediol excretion, during the post-ovulatory phase of the cycle in normal and ergocornine-treated women. Acta Endocrinologica, 56, 35–42.
150. Lombaert GA, Pellaers P, Roscoe V, Mankotia M, Neil R and Scott PM, 2003. Mycotoxins in infant cereal foods from the Canadian retail market. Food Additives and Contaminants. Part A, 20, 494–504.
151. Long SY, 1972. Does LSD induce chromosomal damage and malformations? A review of the literature. Teratology, 6, 75–90.
152. Lorenz K, 1978. Ergot from triticale-chemical composition and rheological characteristics. Lebensmittel-Wissenchaft; und- Technologie, 11, 70 (Abstract).
153. Lorenz K, 1979. Ergot on cereal grains. CRC Critical Reviews in Food Science and Nutrition, 11, 311–354.
154. Lorenz N, Wilson EV, Machado C, Schardl CL and Tudzynski P, 2007. Comparison of ergot alkaloid biosynthesis gene clusters in Claviceps species indicates loss of late pathway steps in evolution of C.fusiformis. Applied and Environmental Microbiology, 73, 7185–7191.
155. Mainka S, Dänicke S, Böhme H, Ueberschär KH and Liebert F, 2007b. On the composition of ergot and the effects of feeding two different ergot sources on piglets. Animal Feed Science and Technology, 139, 52–68.
156. Mainka S, Dänicke S, Böhme H, Ueberschär KH, Polten S and Hüther L, 2005a. The influence of ergot-contaminated feed on growth and slaughtering performance, nutrient digestibility and carry over of ergot alkaloids in growing-finishing pigs. Archives of Animal Nutrition, 59, 377–395.
157. Mainka S, Dänicke S, Böhme H, Ueberschär K-H and Liebert F, 2007a. On the alkaloid content of ergot (Claviceps purpurea). Landbauforschung Volkenrode, 57, 51–59.
158. Mainka S, Dänicke S, Böhme H, Wolff J, Matthes S and Flachowsky G, 2005b. Comparative studies on the effect of ergot contaminated feed on performance and health of piglets and chickens. Archives of Animal Nutrition, 59, 81–98.
159. Malinowski DP, Belesky DP, Hill NS, Baligar VC and Fedders JM, 1998. Influence of phosphorus on the growth and ergot alkaloid content of Neotyphodium coenophialum-infected tall fescue (Festuca arundinacea Schreb.). Plant and Soil, 198, 53–61.
160. Mantegani S, Brambilla E and Varasi M, 1999. Ergoline derivatives: receptor affinity and selectivity. Il Farmaco, 54, 288–296.
161. Mantle P, 1992. Ergot disease of pearl millet: toxicological significance and mechanism for disease escape. In: Sorghum and millet disease: a second world review. Eds De Milano WAJ, Frederiksen RA and Bengston GD. Paanchenu (A.P.) India, 129–132.
162. Mantle PG, 1969. Interruption of early pregnancy in mice by oral administration of agroclavine and sclerotia of Claviceps fusiformis (Loveless). Journal of Reproduction and Fertility, 18, 81–88.
163. Marquardt H and Schaefer S, 2004. Lehrbuch der Toxikologie, 2nd edition. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, Germany.
164. th edition, London, 697–698 pp.
165. Martindale, 2010. The complete drug reference, Ergotamine Tartrate, Ergometrine Maleate; online, Pharmaceutical Press, London, Date of monographs revision: 27 November 2010. Available from www.medicinescomplete.com/mc/martindale/current/.
166. Martos PA, Thompson W and Diaz GJ, 2010. Multiresidue mycotoxin analysis in wheat, barley, oats, rye and maize grain by high-performance liquid chromatography-tandem mass spectrometry. World Mycotoxin Journal, 3, 205–223.
167. Masloff S, 2006. Mutterkornalkaloide in Getreide und Getreideprodukten. Journal für Verbraucherschutz und Lebensmittelsicherheit, 1, 153–154.
168. Matter BE, 1976. Failure to detect chromosome damage in bone-marrow cells of mice and Chinese hamsters exposed in vivo to some ergot derivatives. The Journal of International Medical Research, 4, 382–392.
169. Matter BE, 1982. Heritable translocation test in mice with triethylenemelamine (TEM) and ergotamine. Mutation Research, 104, 177–182.
170. Matter BE, Tsuchimoto T and Deyssenroth H, 1978. Failure to detect dominant-lethal mutations and effects on reproductive capacity in mice exposed to dihydroergotoxine mesylate. Arzneimittelforschung, 28, 2286–2290.
171. Maurer G and Frick W, 1984. Elucidation of the structure and receptor binding studies of the major primary, metabolite of dihydroergotamine in man. European Journal of Clinical Pharmacology, 26, 463–470.
172. Maurer G, Schreier E, Delaborde S, Loosli HR, Nufer R and Shukla AP, 1982. Fate and disposition of bromocriptine in animals and man. I: Structure elucidation of the metabolites. European Journal of Drug Metabolism and Pharmacokinetics, 7, 281–292.
173. Maurer G, Schreier E, Delaborde S, Nufer R and Shukla AP, 1983. Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism. European Journal of Drug Metabolism and Pharmacokinetics, 8, 51–62.
174. th edition. Benjamin Cummings, 712 pp.
175. McNitt JI, Patton NM, Lukefahr SD and Cheeke PR. 2000. Rabbit production. Interstate Publishers Inc. Danville, Illinois, 493 pp.
176. McPhail AT, Sim GA, Frey AJ and Ott H, 1966. Fungal metabolites. Part V. X-Ray; determination of the structure and stereochemistry of new isomers of the ergot alkaloids of the peptide type. Journal of the Chemical Society, Section B 377–395.
177. Merhoff GC and Porter JM, 1974. Ergot intoxication: historical review and description of unusual clinical manifestations. Annals of Surgery, 180, 773–779.
178. Millar M, Smith R and May P, 2010. Ergot poisoning of water buffaloes in the UK. The Veterinary Record, 166, 28–29.
179. Mitchell AA, Lacouture PG and Crone RK, 1983. Accidental administration of ergonovine to a newborn. JAMA, 250, 730–731.
180. Mohamed R, Gremaud E, Richoz-Payot; J, Tabet JC and Guy PA, 2006a. Quantitative determination of five ergot alkaloids in rye flour by liquid chromatography-electrospray ionisation tandem mass spectrometry. Journal of Chromatography. A, 1114, 62–72.
181. Mohamed R, Gremaud E, Tabet JC and Guy PA, 2006b. Mass spectral characterization of ergot alkaloids by electrospray ionization, hydrogen/deuterium exchange, and multiple stage mass spectrometry: Usefulness of precursor ion scan experiments. Rapid Communications in Mass Spectrometry, 20, 2787–2799.
182. Mol HG, Plaza-Bolanos; P, Zomer P, de Rijk TC, Stolker AA and Mulder PP, 2008. Toward a generic extraction method for simultaneous determination of pesticides, mycotoxins, plant toxins, and veterinary drugs in feed and food matrixes. Analytical Chemistry, 80, 9450–9459.
183. Molloy JB, Moore CJ, Bruyeres AG, Murray SA and Blaney BJ, 2003. Determination of dihydroergosine in sorghum ergot using an immunoassay. Journal of Agricultural and Food Chemistry, 51, 3916–3919.
184. Morgan-Jones; G, White JF and Piontelli EL, 1990. Acremonium chilense, and undescribed endophyte occurring in Dactylis glomerata in Chile. Mycotaxon, 39, 441–454.
185. Moubarak AS, Rosenkrans CF and Johnson ZB, 2002. The involvement of cytochrome P450 in ergot alkaloid metabolism. Arkansas Animal Science Department Report Research Series 499, 58–61.
186. Moubarak AS and Rosenkrans CFJ, 2000. Hepatic metabolism of ergot alkaloids in beef cattle by cytochrome P450. Biochemical and Biophysical Research Communications, 274, 746–749.
187. Moyano MR, Molina AM, Lora AJ, Medez J and Rueda A, 2010. Tremorgenic mycotoxicosis caused by Paspalum paspaloides (Michx.) Scribner infected by Claviceps paspali: a case report. Veterinarni Medicina - UZEI (Czech Republic), 55, 336–338.
188. Mukherjee J and Menge M, 2000. Progress and prospects of ergot alkaloid research. Advances in Biochemical Engineering/Biotechnology, 68, 1–20.
189. Mulac D, Grote A-K;, Kleigrewe K and Humpf H-U;, 2011. Investigation of the Metabolism of Ergot Alkaloids in Cell Culture by Fourier Transformation Mass Spectrometry. Journal of Agricultural Food and Chemistry, 59, 7798–7807.
190. Mulac D, Huwel S, Galla HJ and Humpf HU, 2012. Permeability of ergot alkaloids across the blood-brain barrier in vitro and influence on the barrier integrity. Molecular Nutrition & Food Research, 56, 475–485.
191. Mulder PPJ, van Raamsdonk LWD, van Egmond HJ, van der Horst T and de Jong J, 2012. Ergot alkaloids and sclerotia in animal feeds. Dutch survey 2007-2010. RIKILT report 2012.005.
192. Müller C, Klaffke HS, Krauthause W and Wittkowski R, 2006. Determination of ergot alkaloids in rye and rye flour. Mycotoxin Research, 22, 197–200.
193. Muller-Schweinitzer; E, 1984. Pharmacological actions of the main metabolites of dihydroergotamine. European Journal of Clinical Pharmacology, 26, 699–705.
194. Mülller C, Kemmlein S, Klaffke H, Krauthause W, Preiss-Weigert; A and Wittkowski R, 2009. A basic tool for risk assessment: a new method for the analysis of ergot alkaloids in rye and selected rye products. Molecular Nutrition & Food Research, 53, 500–507.
195. Mumme A, Ernst R, Brandt J, Schäfer K and Zumtobel V, 1991. Extremity-threatening ischemia in ergotism. Successful treatment with the intra-arterial administration of nifedipine. Deutsche Medizinische Wochenschrift, 116, 137–140.
196. MVN (The Merck Veterinary Manual), 2011a. Fescue lameness (fescue foot). Available from (www.merckvetmanual.com/mvm/index.jsp?cfile=etm/bc/212209.htm), accessed on 23.01.2012.
197. MVN (The Merck Veterinary Manual), 2011b. Perennial ryegrass staggers. Available from (www.merckvetmanual.com/mvm/index.jsp?cfile=etm/bc/213103.htm), accessed on 23.01.2012.
198. Naudé TW, Botha CJ, Vorster JH, Roux C, Van der Linde EJ, Van der Walt SI, Rottinghaus GE, Van Jaarsveld L and Lawrence AN, 2005. Claviceps cyperi, a new cause of severe ergotism in dairy cattle consuming maize silage and teff hay contaminated with ergotised Cyperus esculentus (nut sedge) on the Highveld of South Africa. The Onderstepoort Journal of Veterinary Research, 72, 23–37.
199. Neef S, Kühn C, Maier S and Schnaufer R, 2009. Untersuchung von Roggenmehlen im Jahr 2009 auf den Gehalt an Mutterkornalkaloide. Die Untersuchungsämter für Lebensmittelüberwachung und Tiergesundheit Baden-W;ürttemberg. Available from www.ua-bw.de/pub/beitrag.asp?subid=0&Thema_ID=12&ID=1241&Pdf=fo. Retrieved 5 March 2012.
200. Nimmerfall F and Rosenthaler J, 1976. Ergot alkaloids: hepatic distribution and estimation of absorption by measurement of total radioactivity in bile and urine. Journal of Pharmacokinetics and Biopharmaceutics, 4, 57–66.
201. NRC (National Research Council), 2007a. Nutrient Requirements of Horses: Sixth Revised Edition. US National Academy of Science, National Academies Press, Washington DC.
202. NRC (National Research Council), 2007b. Nutrient 4244 Requirements of Small Ruminants: Sheep, Goats, Cervids, and New World Camelids. US National Academy of Science, National Academies Press, Washington.
203. Panaccione DG and Annis SL, 2001. Significance of fungal peptide secondary metabolites in the agri-food industry. In: Applied Biology and Biotechnology: Food and Fungi, vol. I. Eds Khachatourians GG and Arora DK. Elsevier, The Netherlands, 115–143.
204. Pandey SK and Haines CI, 1982. Accidental administration of ergometrine to newborn infant. British Medical Journal, 285, 693.
205. Pažoutová S, 2001. The phylogeny and evolution of the genus Claviceps. Mycological Research, 105, 275–283.
206. Pažoutová S, 2002. The evolutionary strategy of Claviceps. In: Clavicipitalean Fungi: Evolutionary Biology, Chemistry, Biocontrol and Cultural Impacts. White JF, Bacon CW, Hywel-Jones; NL (Eds.= Marcel Dekker, New York, Basel, pp. 329–354.
207. Pažoutová S, Olsovska J, Linka M, Kolinska R and Flieger M, 2000. Chemoraces and habitat specialization of Claviceps purpurea populations. Applied and Environmental Microbiology, 66, 5419–5425.
208. Pažoutová S and Parbery DP, 1999. The taxonomy and Phylogeny of Claviceps. In: Ergot. The Genus Claviceps. Eds Kren V and Cvak L. CRC Press, Boca Raton, 57–77.
209. Perz H and Eich E, 1999. Ergot alkaloids and their derivatives as ligands for serotoninergic, dopaminergic, and adrenergic receptors. In: Ergot: the genus Claviceps. Eds Kren C and Cvak L. Harwood Academic Publishers, Amsterdam (NL), 441–440.
210. Peters-Volleberg; GW, Beems RB and Speijers GJ, 1996. Subacute toxicity of ergometrine maleate in rats. Food and Chemical Toxicology, 34, 951–958.
211. Pierri L, Pitman IH, Rae ID, Winkler DA and Andrews PR, 1982. Conformational analysis of the ergot alkaloids ergotamine and ergotaminine. Journal of Medicinal Chemistry, 25, 937–942.
212. Porter JK, 1995. Analysis of endophyte toxins: fescue and other grasses toxic to livestock. Journal of Animal Science, 73, 871–880.
213. Porter JK, Bacon CW, Plattner RD and Arrendale RF, 1987. Ergot Peptide Alkaloid Spectra of Claviceps -Infected Tall Fescue, Wheat, and Barley. Journal of Agricultural Food and Chemistry, 35, 359–361.
214. Redfield MM, Nicholson WJ, Edwards WD and Tajik AJ, 1992. Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations. Annals of Internal Medicine, 117, 50–52.
215. Reinhard H, Rupp H and Zoller O, 2008. Ergot alkaloids: quantitation and recognition challenges. Mycotoxin Research, 24, 7–13.
216. Reinhold L and Reinhardt K, 2011. Mycotoxins in foods in Lower Saxony (Germany): results of official control analyses performed in 2009. Mycotoxin Research, 27, 137–143.
217. Roberts C, 2000. Tall fescue toxicosis. Agricultural MU guide-forages, G4669. University of Missouri-Columbia;. 4 pp. Available from extension.missouri.edu/p/G4669.
218. Roberts C, Kallenbach R and Hill N, 2002. Harvest and storage method affects ergot alkaloid concentration in tall fescue. Crop Management, 1–3.
219. Roberts CA, Benedict HR, Hill NS, Kallenbach RL and Rottinghaus GE, 2005. Determination of Ergot alkaloid content in tall fescue by near-infrared spectroscopy. CropScience, 45, 778–783.
220. Roberts CA, Joost RE and Rottinghaus GE, 1997. Quantification of ergovaline in tall fescue by near infrared reflectance spectroscopy. CropScience, 37, 281–284.
221. Roberts CA, Kallenbach RL, Hill NS, Rottinghaus GE and Evans TJ, 2009. Ergot Alkaloid Concentrations in Tall Fescue Hay during Production and Storage. CropScience, 49, 1496–1502.
222. Roberts G and Rand MJ, 1977a. Chromosomal damage induced by some ergot derivatives in vitro. Mutation Research, 48, 205–214.
223. Roberts GT and Rand MJ, 1977b. Effects of some ergot derivatives in bone marrow of mice. Mutation Research, 56, 59–68.
224. Roberts GT and Rand MJ, 1978. The dominant lethal effects of some ergot alkaloids. Mutation Research, 50, 317–325.
225. Ronca F, Guazzelli M, Salvadori P, Palumbo R, Neuteboom B, Ambrosoli L, Poli A, Girardello R and Lowenthal DT, 1996. Pharmacokinetic and Metabolism Study in Healthy Volunteers After Administration of Single Oral Dose of (3)H-alpha-Dihydroergocryptine; Mesylate. American Journal of Therapeutics, 3, 553–562.
226. Rote Liste, 2003. Ergo sanol Spezial N Kapseln, Arzneimittelverzeichnis für Deutschland. Edition Cantor Verlag.
227. Rottinghaus GE, Schultz LM, Ross PF and Hill NS, 1993. An HPLC method for the detection of ergot in ground and pelleted feeds. Journal of Veterinary Diagnostic Investigation, 5, 242–247.
228. Ruhland M and Tischler J, 2008. Determination of ergot alkaloids in feed by HPLC. Mycotoxin Research, 24, 73–79.
229. Sandoz, 2010. Sandoz History. Available from www.us.sandoz.com/about_us/our_company/history.shtml.
230. Saper JR, 1987. Ergotamine dependency-a review. Headache, 27, 435–438.
231. Schardl CL, Panaccione DG and Tudzynski P, 2006. Ergot Alkaloids - Biology and Molecular Biology. In: The Alkaloids: Chemistry and Biology. Vol. 63. Ed Cordell GA. Academic Press, San Diego, USA, 45–86.
232. Schnitzius JM, Hill NS, Thompson CS and Craig AM, 2001. Semiquantitative determination of ergot alkaloids in seed, straw, and digesta samples using a competitive enzyme-linked immunosorbent assay. Journal of Veterinary Diagnostic Investigation, 13, 230–237.
233. Schön H, Leist KH and Grauwiler J, 1975. Single day treatment of pregnant rats with ergotamine. Teratology 11, 32A.
234. Schumann B, Dänicke S, Hübner S, Ueberschär KH and Meyer U, 2007b. Effects of different levels of ergot in concentrate on the health and performance of male calves. Mycotoxin Research, 23, 43–55.
235. Schumann B, Dänicke S, Meyer U, Ueberschär KH and Breves G, 2007a. Effects of different levels of ergot in concentrates on the growing and slaughtering performance of bulls and on carry-over into edible tissue. Archives of Animal Nutrition, 61, 357–370.
236. Schumann B, Lebzien P, Ueberschär KH and Dänicke S, 2009. Effects of the level of feed intake and ergot contaminated concentrate on ergot alkaloid metabolism and carry over into milk. Molecular Nutrition & Food Research, 53, 931–938.
237. Schwarz PB, Hill NS and Rottinghaus GE, 2007. Fate of ergot (Claviceps purpurea) alkaloids during malting and brewing. Journal of the American Society of Brewing Chemists, 65, 1–8.
238. Scott P, 2007. Analysis of ergot alkaloids – a review. Mycotoxin Research, 23, 113–121.
239. Scott PM, 2009. Ergot alkaloids: extent of human and animal exposure. World Mycotoxin Journal, 2, 141–149.
240. Scott PM and Lawrence GA, 1980. Analysis of ergot alkaloids in flour. Journal of Agricultural and Food Chemistry, 28, 1258–1261.
241. Seifried HE, Seifried RM, Clarke JJ, Junghans TB and San RH, 2006. A compilation of two decades of mutagenicity test results with the Ames Salmonella typhimurium and L5178Y mouse lymphoma cell mutation assays. Chemical Research in Toxicology, 19, 627–644.
242. Shaar CJ and Clemens JA, 1972. Inhibition of Lactation and Prolactin Secretion in Rats by Ergot Alkaloid. Endocrinology, 90, 285–288.
243. Shappell NW and Smith DJ, 2005. Ergovaline movement across Caco-2 cells. In Vitro Cellular and Developmental Biology. Animal, 41, 245–251.
244. Sharma C, Aulerich RJ, Render JA, Reimers T, Rottinghaus GE, Kizilkaya K and Bursian SJ, 2002. Reproductive toxicity of ergot alkaloids in mink. Veterinary and Human Toxicology, 44, 324–327.
245. Shelby RA and Flieger M, 1997. Improved method of analysis for ergovaline in tall fescue by high-performance liquid chromatography. Journal of Agriculture and Food Chemistry, 45, 1797–1800.
246. Shelby RA, Olsovska J, Havlicek V and Flieger M, 1997. Analysis of ergot alkaloids in endophyte-infected tall fescue by liquid chromatography electrospray ionization mass spectrometry. Journal of Agriculture and Food Chemistry, 45, 4674–4679.
247. Shelesnyak MC, 1957. Some experimental studies on the mechanism of ova-implantation in the rat. Recent Progress in Hormone Research, 13, 269–317; discussion 317-222.
248. Shelesnyak MC, Lunenfeld B and Honig B, 1963. Studies on the mechanism of ergocornine interference with decidualization and nidation III urinary steroids after administration of ergocornine to women. Life Sciences, 1, 73–79.
249. Siegel MR, Latch GCM and Johnson MC, 1987. Fungal endophytes of grasses. Annual Review of Phytopathology, 25, 293–315.
250. Silber A and Bischoff W, 1954. Die Konstanz des Alkaloidgehaltes bei ver schiedenen Rassen von Mutterkorn. Pharmazie 9, 239–315.
251. Silberstein SD and McCrory DC, 2003. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. Headache, 43, 144–166.
252. Singh MP, Kalia CS and Jain HK, 1970. Chromosomal aberrations induced in barley by LSD. Science, 169, 491–492.
253. Slaytor MB and Wright SE, 1962. The Metabolites of Ergometrine and Lysergic Acid Diethylamide in Rat Bile. Journal of Medicinal and Pharmaceutical Chemistry, 91, 483–491.
254. Smets K, Zecic A and Willems J, 2004. Ergotamine as a possible cause of Möbius sequence: additional clinical observation. J Child Neurology, 19, 398.
255. Smith DJ and Shappell NW, 2002. Technical note: epimerization of ergopeptine alkaloids in organic and aqueous solvents. Journal of Animal Science, 80, 1616–1622.
256. Smythies JR and Antun F, 1969. Binding of tryptamine and allied compounds to nucleic acids. Nature, 223, 1061–1063.
257. Sommer AF and Buchanan AR, 1955. Effects of ergot alkaloids on pregnancy and lactation in the albino rat. American Journal of Physiology, 180, 296–300.
258. Sommer and Buchanan, 1970
259. Speijers GJA, Krajnc-Franken; MAM, van Leeuwen FXR, SDanse LHJC, Loebeer JG, Elvers LH, Hoejenbos-Spithout; HHM and Janssen GB, 1992. Subacute toxicity experiment with rats fed a diet containing ergotamine tartrate. Report no. 618312001. National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands.
260. Speijers GJA, Wester PN, van Leeuwen FXR, de la Fonteyne-Blankestijn; L, Post W, van Egmond HP, Sizoo EA and Janssen GB, 1993. Subchronic toxicity experiment with rats fed a diet containing ergotamine tartrate. Report no. 618312002. National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands.
261. Šràm RJ, Zudovà Z and Goetz P, 1974. The mutagenic effect of lysergic acid diethylamide. II. Dominant lethal test in mice. Mutation Research, 26, 517–522.
262. Stange K, Pohlmeier H, Lubbesmeyer A, Gumbinger G, Schmitz W and Baumgart P, 1998. Vascular ergotism through inhalation of grain dust. Deutsche medizinische Wochenschrift, 123, 1547–1550.
263. Steiner U, Leibner S, Schardl CL, Leuchtmann A and Leistner E, 2011. Periglandula, a new fungal genus within the Clavicipitaceae and its association with Convolvulaceae. Mycologia, 103, 1133–1145.
264. Sterba R, 1968. Clinical testing of antinidation effect of ergocornine methanesulfonate. Zentralblatt für Gynakologie, 90, 311–314.
265. Stoll A, 1955. Über Belichtungsprodukte von Mutterkornalkaloiden. Helvetica Chimica Acta, 38, 585–594.
266. Storm ID, Rasmussen PH, Strobel BW and Hansen HC, 2008. Ergot alkaloids in rye flour determined by solid-phase cation-exchange and high-pressure liquid chromatography with fluorescence detection. Food Additives & Contaminants. Part A, 25, 338–346.
267. Strickland JR, Looper ML, Matthews JC, Rosenkrans CFJ, Flythe MD and Brown KR, 2011. Board-invited review: St. Anthony's Fire in livestock: causes, mechanisms, and potential solutions. Journal of Animal Science, 89, 1603–1626.
268. Stuedemann JA, Hill NS, Thompson FN, Fayrer-Hosken; RA, Hay WP, Dawe DL, Seman DH and Martin SA, 1998. Urinary and biliary excretion of ergot alkaloids from steers that grazed endophyte-infected tall fescue. Journal of Animal Science, 76, 2146–2154.
269. Sulyok M, Krska R and Schuhmacher R, 2007. A liquid chromatography/tandem mass spectrometric multi-mycotoxin method for the quantification of 87 analytes and its application to semi-quantitative screening of moldy food samples. Analytical and Bioanalytical Chemistry, 389, 1505–1523.
270. Sung GH, Sung JM, Hywel-Jones; NL and Spatafora JW, 2007. A multi-gene phylogeny of Clavicipitaceae (Ascomycota, Fungi): identification of localized incongruence using a combinational bootstrap approach. Molecular Phylogenetics and Evolution, 44, 1204–1223.
271. Tenberge KB, 1999. Biology and Life Strategy of the Ergot Fungi. In: Ergot: The genus Claviceps. Eds Kren V and Cvak L. CRC Press, Boca Raton, FL, USA, 25–56.
272. Tfelt-Hansen; P, Saxena PR, Dahlof C, Pascual J, Lainez M, Henry P, Diener H, Schoenen J, Ferrari MD and Goadsby PJ, 2000. Ergotamine in the acute treatment of migraine: a review and European consensus. Brain, 123 (Pt 1), 9–18.
273. Thakur R and Rai KN, 2002. Pearl millet ergot research: advances and implications. In: Sorghum and millet diseases. Ed Leslie JF. Iowa State Press, Ames, 57–64.
274. Thomas M, van Zuilichem DJ and van der Poel AFB, 1997. Physical quality of pelleted animal feed 2. Contribution of processes and its conditions. Animal Feed Science and Technology, 64, 173–192.
275. Tooley PW, O'Neill NR, Goley ED and Carras MM, 2000. Assessment of Diversity in Claviceps africana and Other Claviceps Species by RAM and AFLP Analyses. Phytopathology, 90, 1126–1130.
276. Tsuchimoto T, Matter BE and Deyssenroth H, 1979. Analysis of chromosome aberrations and sister-chromatid exchanges in human lymphocytes exposed in vitro to Hydergine. Mutation Research, 67, 39–45.
277. Tsuchimoto T and Stalder GR, 1976. Effect of an ergot derivative on human lymphocyte chromosomes in vivo. Arzneimittelforschung, 26, 2101–2103.
278. Tulpule PG and Bhat RV, 1978. Food toxins and their implication in human health. The Indian Journal of Medical Research, 68 Suppl, 99–108.
279. Tunali B, Shelby RA, Morgan-Jones; G and Kodan M, 2000. Endophytic fungi and ergot alkaloids in native Turkish grasses. Phytoparasitica, 28, 375–377.
280. Uhlig S, Botha CJ, Vralstad T, Rolen E and Miles CO, 2009. Indole-diterpenes and ergot alkaloids in Cynodon dactylon (Bermuda grass) infected with Claviceps cynodontis from an outbreak of tremors in cattle. Journal of Agricultural and Food Chemistry, 57, 11112–11119.
281. Uhlig S, Vikøren T, Ivanova L and Handeland K, 2007. Ergot alkaloids in Norwegian wild grasses: a mass spectrometric approach. Rapid Communications in Mass Spectrometry, 21, 1651–1660.
282. Urga K, Debela A, Medihn YW, Agata N, Bayu A and Zewdie W, 2002. Laboratory studies on the outbreak of gangrenous ergotism associated with consumption of contaminated barley in Arsi, Ethiopia. Ethiopian Journal of Health Development, 16, 317–123.
283. Van der Linde EG, 2005. Ergot of nut sedge in South Africa. PhD thesis, Faculty of Natural and Agricultural Sciences, University of Pretoria, The Republic of South Africa. Pretoria, S.A. Chapter 5: pp. 57–69. Available from upetd.up.ac.za/thesis/submitted/etd-08042008-081413/unrestricted/02chapter5-7.pdf.
284. Van der Linde EJ and Wehner FC, 2007. Symptomatology and morphology of Claviceps cyperi on yellow nut sedge in South Africa. Mycologia, 99, 586–591.
285. van Urk HW, 1929. Een nieuwe gevoelige reactie op de moederkoornalkaloiden ergotamine, ergotoxine en ergotinine en de toepassig voor het onderzoek en de colometrische bepaling en moederkoornpreparaten. Pharmaceutisch weekblad voor Nederland, 66, 473–481.
286. Van Vunakis H, Farrow JT, Gjika HB and Levine L, 1971. Specificity of the antibody receptor site to D-lysergamide: model of a physiological receptor for lysergic acid diethylamide. Proceedings of the National Academy of Sciences of the United States of America, 68, 1483–1487.
287. Vann E, 1969. Lethal mutation rate in Drosophila exposed to LSD-25 by injection and ingestion. Nature, 223, 95–96.
288. Vann E, Matlen C and Rossmoore H, 1970. Genetic effects of LSD-25 on E. coli. Mutation Research, 10, 269–275.
289. Varga L, Lutterbeck PM, Pryor JS, Wenner R and Erb H, 1972. Suppression of puerperal lactation with an ergot alkaloid: a double-blind study. British Medical Journal, 2, 743–744.
290. Varona L, Ruiz J, Zarranz JJ, Munoz F and Egurbide MV, 1996. Ergotism: an infrequent aetiology of intermittent claudication. Postgrad Medical Journal, 72, 636.
291. Vermeulen P, Pierna JA, Egmond HP, Dardenne P and Baeten V, 2012. Online detection and quantification of ergot bodies in cereals using near infrared hyperspectral imaging. Food Additives & Contaminants. Part A, 29, 232–240.
292. Wagner TE, 1969. In vitro interaction of LSD with puried calf thymus DNA. Nature, 222, 1170–1172.
293. Walker J (2004) Claviceps phalaridis in Australia: biology, pathology and taxonomy with a description of the new genus Cepsiclava (Hypocreales, Clavicipitaceae). Australasian Plant Pathology 33, 211–39.
294. Wang ZY, Takamizo T, Iglesias VA, Osusky M, Nagel J, Potrykus I and Spangenberg G, 1992. Transgenic plants of tall fescue (Festuca arundinacea Schreb.) obtained by direct gene transfer to protoplasts. Biotechnology, 10, 691–696.
295. Ware GM, Price G, Carter L Jr and Eitenmiller RR, 2000. Liquid chromatographic preparative method for isolating ergot alkaloids, using a particle-loaded membrane extracting disk. Journal of AOAC International, 83, 1395–1399.
296. Westendorf ML, Mitchell GE Jr., Tucker RE, Bush LP, Petroski RJ and Powell RG, 1993. In vitro and in vivo ruminal and physiological responses to endophyte-infected tall fescue. Journal of Dairy Science, 76, 555–563.
297. Whitfield MF and Salfield SA, 1980. Accidental administration of Syntometrine in adult dosage to the newborn. Archives of Disease in Childhood, 55, 68–70.
298. WHO-IPCS; (World Health Organization - International Programme on Chemical Safety), 1990. Selected Mycotoxins: Ochratoxins, Trichothecenes, Ergot. Environmental Health Criteria, 105.
299. WHO-IPCS; (World Health Organization - International Programme on Chemical Safety), 2008. Uncertainty and Data Quality in Exposure Assessment. Part 1: Guidance document on characterizing and communicating uncertainty in exposure assessment. Part 2: Hallmarks of data quality in chemical exposure assessment. Available from www.who.int/ipcs/publications/methods/harmonization/exposure_assessment.pdf.
300. WHO-IPCS; (World Health Organization - International Programme on Chemical Safety), 2009. Principles and Methods for the Risk Assessment of Chemicals in Food. International Programme on Chemical Safety (IPCS), Environmental Health Criteria 240.
301. Wilkinson RE, Hardcastle WS and McCormick CS, 1987. Seed ergot alkaloid contents of Ipomoca hederifolia, I. quamoclit, I. coccinea and I. wrightii. Journal of the Science of Food and Agriculture, 39, 335–339.
302. Wirth W and Gloxhuber C, 1981. Toxikologie. 3rd edition. Thieme Verlag, Stuttgart, Germany, 1539 pp.
303. Witters WL, Wilms RA and Hood RD, 1975. Prenatal effects of elymoclavine administration and temperature stress. Journal of Animal Science, 41, 1700–1705.
304. Wolff J, Neudecker C, Klug C and Weber R, 1988. Chemical and toxicologic studies of native corn in flour and bread. Zeitschrift für Ernahrungswissenschaft, 27, 1–22.
305. Wolff J, Ocker H-D; and Zwingelberg H, 1983. Bestimmung von Mutterkornalkaloiden in Getreide und Mahlprodukten durch HPLC. Veröffentlichungs-Nr;.5113 der Bundesforschungsanstalt für Getreide-und Kartoffelverarbeitung, Detmold.
306. Wooltorton E, 2003. Risk of stroke, gangrene from ergot drug interactions. Canadian Medical Association Journal, 168, 1015.
307. Young JC, 1981a. Variability in the content and composition of alkaloids found in Canadian ergot. I. Rye. Journal of Environmental Science and Health. Part. B, 16, 83–111.
308. Young JC, 1981b. Variability in the content and composition of alkaloids found in Canadian ergot. II. Wheat. Journal of Environmental Science and Health. Part. B, 16, 381–393.
309. Young JC and Chen ZJ, 1982. Variability in the content and composition of alkaloid found in Canadian ergot. III. Triticale and barley. Journal of Environmental Science and Health. Part. B, 17, 93–107.
310. Zachariasova M, Cajka T, Godula M, Malachova A, Veprikova Z and Hajslova J, 2010. Analysis of multiple mycotoxins in beer employing (ultra)-high-resolution mass spectrometry. Rapid Communications in Mass Spectrometry, 24, 3357–3367.
311. Zakhari NA, Hassan SM and El-Shabrawy; Y, 1991. Colorimetric determination of beta-adrenergic blocking drugs with carbon disulphide and copper (I) ions. Journal of Pharmaceutical and Biomedical Analysis, 9, 421–426.
312. Zavaleta EG, Fernandez BB, Grove MK and Kaye MD, 2001. St. Anthony's fire (ergotamine induced leg ischemia)–a case report and review of the literature. Angiology, 52, 349–356.
313. Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K and Speck W, 1987. Salmonella Mutagenicity tests: III. Results from the testing of 255 chemicals. Environmental Mutagenesis, 9, 1–109.
314. Zeilmaker GH and Carlsen RA, 1962. Experimental studies on the effect of ergocornine methanesulphonate on the luteotrophic function of the rat pituitary gland. Acta Endocrinologica, 41, 321–335.